Athyrium Capital Management

Athyrium Capital Management is a New York-based healthcare-focused investment management firm advising funds with over $4.6 billion of committed capital. It provides flexible financing to healthcare and life sciences companies across biotechnology, pharmaceuticals, medical devices, healthcare technology and oncology, with a global mandate and activity in the United States and United Kingdom. The firm backs early-stage and commercial-stage healthcare businesses and has made investments of up to $200 million per company.